Engineers Gate Manager’s Vanda Pharmaceuticals VNDA Stock Holding History

Engineers Gate Manager’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Sell	34,477 -17,105	-33%	-$112K	﹤0.01%	1941
2026 Q1	$356K	Buy	+51,582	New	+$398K	﹤0.01%	1617
2025 Q4	–	Sell	-12,867	Closed	-$64.2K	–	2587
2025 Q3	$64.2K	Sell	12,867 -2,939	-19%	-$13.6K	﹤0.01%	2042
2025 Q2	$74.6K	Buy	+15,806	New	+$69.1K	﹤0.01%	2028
2024 Q2	–	Sell	-19,345	Closed	-$79.5K	–	2253
2024 Q1	$79.5K	Buy	+19,345	New	+$77.4K	﹤0.01%	1770
2023 Q4	–	Sell	-61,140	Closed	-$264K	–	2285
2023 Q3	$264K	Buy	61,140 +38,817	+174%	+$216K	0.01%	1379
2023 Q2	$147K	Buy	22,323 +4,777	+27%	+$30.6K	0.01%	1516
2023 Q1	$119K	Sell	17,546 -20,640	-54%	-$145K	0.01%	1495
2022 Q4	$282K	Buy	+38,186	New	+$372K	0.02%	1212
2022 Q3	–	Sell	-31,720	Closed	-$346K	–	2100
2022 Q2	$346K	Buy	+31,720	New	+$329K	0.01%	1319
2022 Q1	–	Sell	-14,280	Closed	-$224K	–	2337
2021 Q4	$224K	Buy	+14,280	New	+$249K	0.01%	1581
2021 Q2	–	Sell	-21,670	Closed	-$325K	–	2042
2021 Q1	$325K	Buy	+21,670	New	+$351K	0.02%	1266
2020 Q4	–	Sell	-30,723	Closed	-$297K	–	2007
2020 Q3	$297K	Buy	30,723 +18,833	+158%	+$201K	0.01%	1255
2020 Q2	$136K	Buy	+11,890	New	+$135K	0.01%	1526
2019 Q4	–	Sell	-24,609	Closed	-$327K	–	1853
2019 Q3	$327K	Buy	24,609 +999	+4%	+$13.9K	0.02%	970
2019 Q2	$333K	Buy	+23,610	New	+$376K	0.02%	841

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's VNDA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Vanda Pharmaceuticals (VNDA) stake by 33% in Q2 2026, selling an estimated $112K and leaving 34,477 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

Engineers Gate Manager first reported a position in VNDA in Q2 2019 and has held it in 16 quarters since. The position peaked at $356K in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Engineers Gate Manager held 34,477 shares of Vanda Pharmaceuticals worth $211K as of Q2 2026.
Engineers Gate Manager sold 17,105 Vanda Pharmaceuticals shares in Q2 2026, an estimated $112K.
Vanda Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1941 holding.
Engineers Gate Manager first reported a position in Vanda Pharmaceuticals in Q2 2019 and has held it in 16 quarters since.
Engineers Gate Manager's Vanda Pharmaceuticals position peaked at $356K in Q1 2026.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.